To the top

Page Manager: Webmaster
Last update: 9/11/2012 3:13 PM

Tell a friend about this page
Print version

Novel immunostimulatory a… - University of Gothenburg, Sweden Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Novel immunostimulatory agent based on CpG oligodeoxynucleotide linked to the nontoxic B subunit of cholera toxin.

Journal article
Authors Jenni Adamsson
Marianne Lindblad
Annika Lundqvist
Denise Kelly
Jan Holmgren
Ali M Harandi
Published in Journal of immunology (Baltimore, Md. : 1950)
Volume 176
Issue 8
Pages 4902-13
ISSN 0022-1767
Publication year 2006
Published at Institute of Biomedicine, Department of Microbiology and Immunology
Pages 4902-13
Language en
Links www.ncbi.nlm.nih.gov/entrez/query.f...
Keywords 1-Phosphatidylinositol 3-Kinase, metabolism, Adaptor Proteins, Signal Transducing, metabolism, Adjuvants, Immunologic, chemistry, genetics, pharmacology, Animals, Base Sequence, Chemokines, biosynthesis, Cholera Toxin, chemistry, genetics, pharmacology, Cytokines, biosynthesis, Drug Design, Endosomes, drug effects, metabolism, G(M1) Ganglioside, pharmacology, Humans, Hydrogen-Ion Concentration, Immunoconjugates, chemistry, genetics, pharmacology, Leukocytes, Mononuclear, drug effects, immunology, Mice, Mice, Inbred C3H, Mice, Inbred C57BL, Mice, Knockout, Myeloid Differentiation Factor 88, NF-kappa B, metabolism, Oligodeoxyribonucleotides, chemistry, genetics, pharmacology, Recombinant Proteins, chemistry, genetics, pharmacology, Species Specificity, Toll-Like Receptor 9, metabolism
Subject categories Medical and Health Sciences

Abstract

In this study, we report the development of a novel, rationally designed immunostimulatory adjuvant based on chemical conjugation of CpG oligodeoxynucleotide (ODN) to the nontoxic B subunit of cholera toxin (CTB). We demonstrate that the immunostimulatory effects of CpG can be dramatically enhanced by conjugation to CTB. Thus, CpG ODN linked to CTB (CTB-CpG) was shown to be a more potent stimulator of proinflammatory cytokine and chemokine responses in murine splenocytes and human PBMCs than those of CpG ODN alone in vitro. The presence of CpG motif, but not modified phosphorothioate ODN backbone, was found to be critical for the enhanced immunostimulatory effects of CTB-CpG. Our mode-of-action studies, including studies on cells from specifically gene knockout mice suggest that similar to CpG, CTB-CpG exerts its immunostimulatory effects through a TLR9/MyD88- and NF-kappaB-dependent pathway. Surprisingly, and as opposed to CpG ODN, CTB-CpG-induced immunity was shown to be independent of endosomal acidification and resistant to inhibitory ODN. Furthermore, preincubation of CTB-CpG with GM1 ganglioside reduced the immunostimulatory effects of CTB-CpG to those of CpG ODN alone. Interestingly, conjugation of CpG ODN to CTB confers an enhanced cross-species activity to CpG ODN. Furthermore, using tetanus toxoid as a vaccine Ag for s.c. immunization, CTB-CpG markedly enhanced the Ag-specific IgG Ab response and altered the specific pattern of Ab isotypes toward a Th1 type response. To our knowledge, CTB is the first nontoxic derivative of microbial toxins discovered that when chemically linked to CpG remarkably augments the CpG-mediated immune responses.

Page Manager: Webmaster|Last update: 9/11/2012
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?